GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hi-Clearance Inc (ROCO:1788) » Definitions » Cyclically Adjusted PS Ratio

Hi-Clearance (ROCO:1788) Cyclically Adjusted PS Ratio : 1.38 (As of Jun. 09, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Hi-Clearance Cyclically Adjusted PS Ratio?

As of today (2024-06-09), Hi-Clearance's current share price is NT$144.00. Hi-Clearance's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was NT$104.28. Hi-Clearance's Cyclically Adjusted PS Ratio for today is 1.38.

The historical rank and industry rank for Hi-Clearance's Cyclically Adjusted PS Ratio or its related term are showing as below:

ROCO:1788' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.18   Med: 1.42   Max: 1.83
Current: 1.38

During the past years, Hi-Clearance's highest Cyclically Adjusted PS Ratio was 1.83. The lowest was 1.18. And the median was 1.42.

ROCO:1788's Cyclically Adjusted PS Ratio is ranked better than
63.31% of 477 companies
in the Medical Devices & Instruments industry
Industry Median: 2.17 vs ROCO:1788: 1.38

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Hi-Clearance's adjusted revenue per share data for the three months ended in Mar. 2024 was NT$21.659. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is NT$104.28 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Hi-Clearance Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Hi-Clearance's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hi-Clearance Cyclically Adjusted PS Ratio Chart

Hi-Clearance Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.25 1.42 1.60 1.43

Hi-Clearance Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.43 1.42 1.43 1.35 1.34

Competitive Comparison of Hi-Clearance's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Hi-Clearance's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hi-Clearance's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hi-Clearance's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Hi-Clearance's Cyclically Adjusted PS Ratio falls into.



Hi-Clearance Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Hi-Clearance's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=144.00/104.28
=1.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hi-Clearance's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Hi-Clearance's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=21.659/131.7762*131.7762
=21.659

Current CPI (Mar. 2024) = 131.7762.

Hi-Clearance Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 18.009 99.695 23.804
201406 19.283 100.560 25.269
201409 18.938 100.428 24.849
201412 19.463 99.070 25.888
201503 17.709 99.621 23.425
201506 19.380 100.684 25.365
201509 19.041 100.392 24.994
201512 20.977 99.792 27.700
201603 19.274 100.470 25.280
201606 20.019 101.688 25.942
201609 20.031 101.861 25.914
201612 20.321 101.863 26.289
201703 19.957 102.862 25.567
201706 21.022 103.349 26.804
201709 21.309 104.136 26.965
201712 21.002 104.011 26.608
201803 21.691 105.290 27.148
201806 21.707 106.317 26.905
201809 21.640 106.507 26.774
201812 22.391 105.998 27.836
201903 22.783 107.251 27.993
201906 21.745 108.070 26.515
201909 20.566 108.329 25.017
201912 19.876 108.420 24.158
202003 20.297 108.902 24.560
202006 22.032 108.767 26.693
202009 21.891 109.815 26.269
202012 21.010 109.897 25.193
202103 21.565 111.754 25.429
202106 24.724 114.631 28.422
202109 22.161 115.734 25.233
202112 22.014 117.630 24.662
202203 24.205 121.301 26.295
202206 43.443 125.017 45.792
202209 24.452 125.227 25.731
202212 23.315 125.222 24.535
202303 23.995 127.348 24.829
202306 21.565 128.729 22.076
202309 22.085 129.860 22.411
202403 21.659 131.776 21.659

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hi-Clearance  (ROCO:1788) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Hi-Clearance Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Hi-Clearance's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hi-Clearance (ROCO:1788) Business Description

Traded in Other Exchanges
N/A
Address
No. 2, Chongzhong Road, Lane 609, 8th Floor, Section 5, Taipei, TWN
Hi-Clearance Inc manufactures medical devices. It is engaged in the biochemical reagents and western medicine trading business. Its products are dialyzer, dialysis machine, RO machine, cardiac, radiation and implant surgery devices, dental consumables implant material & equipments & blood glucose monitor & nutrition products.

Hi-Clearance (ROCO:1788) Headlines

No Headlines